通过调节IL-6/STAT3,ZO-1和S1P通路治疗梅萨拉的性结肠炎患者的西菲林:一项随机对照双盲研究
Mostafa M Bahaa1, Sahar K Hegazy2, Maha M Maher3,4
1Pharmacy Practice Department, Faculty of Pharmacy, Horus University, New Damietta, Egypt. mostafabahaamnf@gmail.com.
Inflammopharmacology
|August 27, 2024
概括
托西菲林 (PTX) 显著减少了性结肠炎 (UC) 患者的炎症和疼痛. 这表明PTX可能是标准UC治疗的有益补充,以改善患者的治疗结果.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 性结肠炎 (UC) 是一种具有复杂病因的慢性炎症性肠病 (IBD).
- 了解新的治疗目标对于管理UC至关重要.
研究的目的:
- 评估pentoxifylline (PTX) 作为轻度至中度UC患者的辅助疗法的疗效.
- 评估PTX对炎症标志物,疾病活动和生活质量的影响.
主要方法:
- 一项为期24周的随机临床试验,涉及52名UC患者.
- 梅萨拉加安慰剂和梅萨拉加PTX (400毫克两次) 的比较. ) 的情况.
- 评估疾病活动 (DAI),疼痛 (NRS),生活质量 (SF-36),炎症标志物 (IL-6,S1P,TNF-α,MPO) 和基因/蛋白质表达 (STAT-3,ZO-1).
主要成果:
- PTX组的血清S1P,TNF-α,IL-6,便MPO和STAT-3基因表达水平显著降低.
- 与梅沙胺组相比,PTX组观察到ZO-1表达的显著增加.
- 接受PTX治疗的患者显示DAI和NRS显著减少,SF-36得分显著改善.
结论:
- 托西菲林在缓解炎症和改善UC患者的临床结果方面表现出潜力.
- 在治疗性结肠炎方面,PTX可能是有前途的辅助治疗选择.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
130
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
130
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
145
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
145
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
98
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
98
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
329
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
329
Inflammatory Bowel Disease IV: Pharmacological Management
123
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
123


